NOTIZIE
COMUNICATI STAMPA
Impulse Dynamics®’ INTEGRA-D Trial Completes Efficacy Phase
PRESS RELEASE First phase of enrollment of single device for CCM® and ICD therapy complete MARLTON, N.J., April 28, 2025 (GLOBE NEWSWIRE) — Impulse Dynamics® plc, a global medical device company dedicated to improving the lives of people with heart failure (HF), is...
Impulse Dynamics Receives European CE Mark For Expanded Indication For Diastolic Heart Failure
PRESSÂ RELEASE CCM therapy is now indicated for symptomatic heart failure patients with diastolic or systolic ventricular dysfunction, offering a broader range of patients a new option for improving quality of life and reducing heart failure hospitalization MARLTON,...
Impulse Dynamics Expands Executive Leadership Team
PRESS RELEASE Extensive depth of experience comes with new leaders – Chief Operating Officer,Chief Financial Officer, Chief Administrative Officer and Chief Science and Strategy Officer MARLTON, N.J., September 24, 2024 (GLOBE NEWSWIRE) — Impulse Dynamics plc, a...
Impulse Dynamics Surpasses 10,000 Patients Benefiting from CCM® Therapy for Heart Failure
PRESS RELEASE Milestone Highlights Transformative SymptomManagement for Patients Living with Heart Failure MARLTON, N.J., May 13, 2024 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure...
Impulse Dynamics Completes $136M Financing Round
PRESS RELEASE Continued Progress Earns Financing to AccelerateCommercial Growth and Advancing Pipeline MARLTON, N.J., February 14, 2024 (GLOBE NEWSWIRE) — Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart...
Impulse Dynamics Receives Full-Body MRI-Conditional Approval for Optimizer Smart Mini System
PRESS RELEASE Reflecting Company Commitment to Innovation in Support of Patient Need MARLTON, N.J., October 30, 2023 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), announced...
Impulse Dynamics Announces Leadership Changes
PRESSÂ RELEASE Jason Spees Appointed to Chief Executive OfficerShlomi Nachman To Be Chairman and John Liddicoat To Join the Board of DirectorsExpanding Depth of Medical Device Industry Leadership and Track Record of Driving Commercialization Success With Advanced...
Impulse Dynamics Announces First Implant for CCM-Dâ„¢ Clinical Trial
PRESS RELEASE World’s First Device Combining CCM Therapy With an ICD in a Single Rechargeable Implant That Treats Both Heart Failure Symptoms and Sudden Cardiac Death MARLTON, N.J., May 18, 2023 (GLOBE NEWSWIRE) — Impulse Dynamics plc, a global medical device company...
Impulse Dynamics Announces 9,000th Patient Milestone Achieved With CCM® Therapy for Heart Failure
PRESS RELEASE Momentum Continues as Depth of Clinical Experience Expands Worldwide MARLTON, N.J., May 15, 2023 (GLOBE NEWSWIRE) — Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure (HF), announced today...
Impulse Dynamics Announces 100th Implant Milestone in China for CCM® Therapy
PRESS RELEASE Experience Continues to Show CCM Therapy Addresses Clinical Need in Treating Heart Failure MARLTON, N.J., November 16, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart...
© 2024 Impulse Dynamics       Condizioni di utilizzo | Protezione dei dati | Note legali | Privacy Policy